Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32
United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Fady Ibraham Malik
3 Nov 2026
EVP Research & Development
Sold after exercise
3,500
$62.93
$220.26K
Robert I Blum
2 Nov 2026
President & CEO
Sold after exercise
7,500
$62.81
$471.08K
Fady Ibraham Malik
20 Oct 2026
EVP Research & Development
Sold after exercise
3,500
$64.01
$224.04K
Robert I Blum
12 Oct 2026
President & CEO
Sold after exercise
7,500
$62.88
$471.60K
Fady Ibraham Malik
6 Oct 2026
EVP Research & Development
Sold after exercise
3,500
$61.38
$214.83K
Robert I Blum
28 Sep 2026
President & CEO
Sold after exercise
7,500
$65.46
$490.95K
Fady Ibraham Malik
22 Sep 2026
EVP Research & Development
Sold after exercise
3,500
$68.29
$239.02K
Robert I Blum
14 Sep 2026
President & CEO
Sold after exercise
7,500
$73.44
$550.80K
Fady Ibraham Malik
8 Sep 2026
EVP Research & Development
Sold after exercise
3,500
$75.46
$264.11K
Robert I Blum
31 Aug 2026
President & CEO
Sold after exercise
7,500
$70.24
$526.80K
Andrew Callos
31 Aug 2026
EVP, Chief Commercial Officer
Sold after exercise
10,000
$70.24
$702.40K
Fady Ibraham Malik
18 Aug 2026
EVP Research & Development
Sold after exercise
3,500
$75.82
$265.37K
Robert I Blum
10 Aug 2026
President & CEO
Sold after exercise
7,500
$76.76
$575.70K
Andrew Callos
30 Jul 2026
EVP, Chief Commercial Officer
Sold after exercise
14,000
$79.88
$1.12M
Robert I Blum
27 Jul 2026
President & CEO
Sold after exercise
7,500
$80.87
$606.53K
Fady Ibraham Malik
21 Jul 2026
EVP Research & Development
Sold after exercise
3,500
$80.59
$282.07K
Robert I Blum
13 Jul 2026
President & CEO
Sold after exercise
7,490
$82.02
$614.33K
Robert I Blum
13 Jul 2026
President & CEO
Sold after exercise
10
$82.02
$820.20
Fady Ibraham Malik
7 Jul 2026
EVP Research & Development
Sold after exercise
3,500
$86.62
$303.17K
Sung Lee
1 Jul 2026
EVP, Chief Financial Officer
Sold after exercise
1,112
$87.79
$97.62K
Andrew Callos
1 Jul 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$85.80
$1.29M
Sung Lee
29 Jun 2026
EVP, Chief Financial Officer
Sold after exercise
3,134
$85.00
$266.39K
Sung Lee
24 Jun 2026
EVP, Chief Financial Officer
Sold after exercise
38,730
$82.30
$3.19M
Fady Ibraham Malik
23 Jun 2026
EVP Research & Development
Sold after exercise
3,500
$79.51
$278.29K
Fady Ibraham Malik
9 Jun 2026
EVP Research & Development
Sold after exercise
3,500
$67.98
$237.93K
Andrew Callos
1 Jun 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$74.08
$1.11M
Fady Ibraham Malik
19 May 2026
EVP Research & Development
Sold after exercise
3,500
$75.69
$264.92K
Andrew Callos
5 May 2026
EVP, Chief Commercial Officer
Sold after exercise
11,333
$77.25
$875.47K
John T Henderson
5 May 2026
Director
Sold after exercise
20,000
$75.97
$1.52M
Wendell Wierenga
5 May 2026
Director
Sold after exercise
4,032
$75.00
$302.40K
Fady Ibraham Malik
5 May 2026
EVP Research & Development
Sold after exercise
3,500
$77.37
$270.80K
Andrew Callos
1 May 2026
EVP, Chief Commercial Officer
Sold after exercise
15,857
$65.00
$1.03M
Andrew Callos
30 Apr 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$63.26
$948.90K
Fady Ibraham Malik
21 Apr 2026
EVP Research & Development
Sold after exercise
3,500
$65.69
$229.92K
Fady Ibraham Malik
7 Apr 2026
EVP Research & Development
Sold after exercise
1,000
$64.75
$64.75K
Fady Ibraham Malik
7 Apr 2026
EVP Research & Development
Sold after exercise
3,500
$65.21
$228.24K
Andrew Callos
5 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
11,000
$61.88
$680.68K
Andrew Callos
5 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$61.87
$928.05K
Andrew Callos
2 Mar 2026
EVP, Chief Commercial Officer
Sold after exercise
886
$61.62
$54.60K
Andrew Callos
5 Feb 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$61.93
$928.95K
Andrew Callos
2 Feb 2026
EVP, Chief Commercial Officer
Sold after exercise
886
$62.10
$55.02K
Andrew Callos
5 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
15,000
$60.28
$904.20K
Andrew Callos
2 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
885
$63.16
$55.90K
Andrew Callos
2 Jan 2026
EVP, Chief Commercial Officer
Sold after exercise
913
$62.09
$56.69K
Wendell Wierenga
22 Dec 2025
Director
Sold after exercise
20,000
$66.14
$1.32M
Fady Ibraham Malik
16 Dec 2025
EVP Research & Development
Sold after exercise
2,200
$61.24
$134.73K
Andrew Callos
8 Dec 2025
EVP, Chief Commercial Officer
Sold after exercise
1,042
$65.96
$68.73K
Andrew Callos
5 Dec 2025
EVP, Chief Commercial Officer
Sold after exercise
52,486
$65.95
$3.46M
Fady Ibraham Malik
2 Dec 2025
EVP Research & Development
Sold after exercise
2,200
$63.89
$140.56K
John T Henderson
2 Dec 2025
Director
Sold after exercise
8,750
$63.90
$559.13K
Edward M. MD Kaye
1 Dec 2025
Director
Sold after exercise
28,064
$66.72
$1.87M
Fady Ibraham Malik
18 Nov 2025
EVP Research & Development
Sold after exercise
2,200
$66.45
$146.19K
Edward M. MD Kaye
11 Nov 2025
Director
Sold after exercise
5,175
$65.08
$336.79K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 53
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,087,174
History held since 3 Oct 2006